Learn About Orchiectomy

Who are the top Orchiectomy Local Doctors?
Learn about our expert tiers
Learn more
What are the Latest Advances for Orchiectomy?
Rare case of pancreatic adenocarcinoma with spermatic cord and testicular metastasis.
Long-term complete remission of HIV-negative primary testicular plasmablastic lymphoma treated with bortezomib in combination with EPOCH.
Tired of the same old research?
Check Latest Advances
Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study.
What are the latest Orchiectomy Clinical Trials?
Open-label Study of Androgen Receptor Inhibition With dArolutamide Plus Androgen Deprivation Therapy (ADT) Versus ADT in Men With Metastatic Hormone-Sensitive Prostate Cancer Using an External Control Arm

Summary: The purpose of the study is to assess if the addition of darolutamide to ADT compared with ADT alone would result in superior clinical efficacy in participants with metastatic hormone-sensitive prostate cancer (mHSPC) by progression-free survival. The researchers want to learn how long it takes for the cancer to get worse (also known as progression-free survival) by either increasing symptoms, new...

Match to trials
Find the right clinical trials for you in under a minute
Get started
China ARCHES: A Multicenter, Phase 3, Randomized, Double-blind, Placebo Controlled Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Summary: The purpose of this study is to evaluate the efficacy and safety of enzalutamide plus androgen deprivation therapy (ADT) versus placebo plus ADT in Chinese subjects with metastatic hormone sensitive prostate cancer (mHSPC). The study will be conducted in two phases: Double-Blind treatment phase and open-label phase.